Physician profile
Sofia Beg
NPI 1285263277
$1,061.56
in general payments reported to CMS, 2019-2025
17 companies · $864 in 2025
The $864 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $73.21 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $187.64 | 2025 | Omnipod, Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.91 | 2022-2025 | Jardiance |
| Corcept Therapeutics | $103.17 | 2025 | Korlym |
| Lilly USA, LLC | $85.85 | 2025 | Mounjaro, Zepbound |
| Pfizer INC. | $73.21 | 2023 | |
| Sanofi-Aventis U.S. LLC | $65.83 | 2025 | |
| Tolmar, INC. | $54.02 | 2025 | Fensolvi |
| Xeris Pharmaceuticals, INC. | $49.61 | 2025 | Gvoke Hypopen |
| Dexcom, INC. | $40.20 | 2025 | Dexcom G6 Transmitter |
| Madrigal Pharmaceuticals | $40.03 | 2025 | Rezdiffra |
| Cequr Corporation | $33.80 | 2025 | Cequr Simplicity |
| Soleno Therapeutics, INC. | $30.34 | 2025 | Vykat Xr |
| Averitas Pharma INC. | $28.16 | 2025 | Qutenza |
| Antares Pharma, INC. | $27.56 | 2025 | Xyosted |
| Tandem Diabetes Care, INC. | $25.31 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $19.49 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $19.43 | 2025 | Yorvipath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Beg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.